𝔖 Bobbio Scriptorium
✦   LIBER   ✦

140 oral Using biological models as a way of determining the efficacyof IMRT for the prostate

Book ID
119512009
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
139 KB
Volume
61
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can prostate-specific antigen be used as
Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?
✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner πŸ“‚ Article πŸ“… 1996 πŸ› Springer-Verlag 🌐 English βš– 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c